The uPA/uPA receptor system as a target for tumor therapy.
about
Pathobiology of brain metastases.Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancerMultifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
P2860
The uPA/uPA receptor system as a target for tumor therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The uPA/uPA receptor system as a target for tumor therapy.
@en
The uPA/uPA receptor system as a target for tumor therapy.
@nl
type
label
The uPA/uPA receptor system as a target for tumor therapy.
@en
The uPA/uPA receptor system as a target for tumor therapy.
@nl
prefLabel
The uPA/uPA receptor system as a target for tumor therapy.
@en
The uPA/uPA receptor system as a target for tumor therapy.
@nl
P2093
P1476
The uPA/uPA receptor system as a target for tumor therapy
@en
P2093
P304
P577
2001-09-01T00:00:00Z